Recombinant multi-species LAMA5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LAMA5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes one of the vertebrate laminin alpha chains. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. The protein encoded by this gene is the alpha-5 subunit of of laminin-10 (laminin-511), laminin-11 (laminin-521) and laminin-15 (laminin-523). [provided by RefSeq, Jun 2013]
The Alternative Names of target: BBDS2,LAMA5,Lama5,Laminin subunit alpha-5,Laminin-10 subunit alpha,Laminin-11 subunit alpha,Laminin-15 subunit alpha,NPHS26,[a]5,laminin-511,mKIAA0533

Target products collectionGo to LAMA5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0299-Ag-1/ GM-Tg-hg-SE0299-Ag-2 Human LAMA5 protein Human
GM-Tg-rg-SE0299-Ag-1/ GM-Tg-rg-SE0299-Ag-2 Rat LAMA5 protein Rat
GM-Tg-mg-SE0299-Ag-1/ GM-Tg-mg-SE0299-Ag-2 Mouse LAMA5 protein Mouse
GM-Tg-cynog-SE0299-Ag-1/ GM-Tg-cynog-SE0299-Ag-2 Cynomolgus/Rhesus macaque LAMA5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0299-Ag-1/ GM-Tg-felg-SE0299-Ag-2 Feline LAMA5 protein Feline
GM-Tg-cang-SE0299-Ag-1/ GM-Tg-cang-SE0299-Ag-2 Canine LAMA5 protein Canine
GM-Tg-bovg-SE0299-Ag-1/ GM-Tg-bovg-SE0299-Ag-2 Bovine LAMA5 protein Bovine
GM-Tg-equg-SE0299-Ag-1/ GM-Tg-equg-SE0299-Ag-2 Equine LAMA5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0299-Ag-1/ GM-Tg-hg-SE0299-Ag-2; GM-Tg-rg-SE0299-Ag-1/ GM-Tg-rg-SE0299-Ag-2;
GM-Tg-mg-SE0299-Ag-1/ GM-Tg-mg-SE0299-Ag-2; GM-Tg-cynog-SE0299-Ag-1/ GM-Tg-cynog-SE0299-Ag-2;
GM-Tg-felg-SE0299-Ag-1/ GM-Tg-felg-SE0299-Ag-2; GM-Tg-cang-SE0299-Ag-1/ GM-Tg-cang-SE0299-Ag-2;
GM-Tg-bovg-SE0299-Ag-1/ GM-Tg-bovg-SE0299-Ag-2; GM-Tg-equg-SE0299-Ag-1/ GM-Tg-equg-SE0299-Ag-2
Products Name LAMA5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name LAMA5
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LAMA5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.